Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neoantigen Targeted Therapies industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Precision Biologics
Gradalis
Genocea Biosciences
Neon Therapeutics
Iovance Biotherapeutics
Vaxon Biotech
Bavarian Nordic
Immunovative Therapies
Immunicum
Medigene
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Monotherapy
Combination Therapy
Application:
Medical Research Institution
Hospital and Clinic
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Neoantigen Targeted Therapies Industry Overview
-
1.1.1 Neoantigen Targeted Therapies Market Scope and Market Segments
-
1.1.2 Neoantigen Targeted Therapies Industry Characteristics
-
1.1.3 Global and China Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Neoantigen Targeted Therapies Production Value and Growth Rate (2017-2028)
-
1.2 Global Neoantigen Targeted Therapies Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Monotherapy
-
1.2.2 Combination Therapy
-
1.3 Global Neoantigen Targeted Therapies Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Medical Research Institution
-
1.3.2 Hospital and Clinic
-
1.3.3 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Neoantigen Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Neoantigen Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Neoantigen Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Neoantigen Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Neoantigen Targeted Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Neoantigen Targeted Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Neoantigen Targeted Therapies Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Neoantigen Targeted Therapies Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Neoantigen Targeted Therapies Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Neoantigen Targeted Therapies Industry Porter's Five Forces Model Analysis
-
2.2.3 Neoantigen Targeted Therapies Industry PEST Analysis
-
2.3 Neoantigen Targeted Therapies Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Neoantigen Targeted Therapies Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Neoantigen Targeted Therapies Industry
Chapter 3 Global and China Neoantigen Targeted Therapies Market, by Manufacturer
-
3.1 Global and China Neoantigen Targeted Therapies Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Neoantigen Targeted Therapies Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Neoantigen Targeted Therapies Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Neoantigen Targeted Therapies Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Neoantigen Targeted Therapies Market Top 3 Players
Chapter 4 Global and China Neoantigen Targeted Therapies Market, by Type (2017-2028)
-
4.1 Neoantigen Targeted Therapies Market Trend, by Type
-
4.2 Global Neoantigen Targeted Therapies Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Neoantigen Targeted Therapies Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Neoantigen Targeted Therapies Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Neoantigen Targeted Therapies Price Trend, by Type (2017-2028)
-
4.3 China Neoantigen Targeted Therapies Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Neoantigen Targeted Therapies Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Neoantigen Targeted Therapies Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Neoantigen Targeted Therapies Price Trend, by Type (2017-2028)
Chapter 5 Global and China Neoantigen Targeted Therapies Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Neoantigen Targeted Therapies Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Neoantigen Targeted Therapies Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Neoantigen Targeted Therapies Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Neoantigen Targeted Therapies Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Neoantigen Targeted Therapies Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Neoantigen Targeted Therapies Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Neoantigen Targeted Therapies Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Neoantigen Targeted Therapies Market Analysis
-
7.1 North America Neoantigen Targeted Therapies Market, by Type
-
7.2 North America Neoantigen Targeted Therapies Market, by Application
-
7.3 North America Neoantigen Targeted Therapies Market Analysis and Forecast, by Country
-
7.3.1 United States Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Neoantigen Targeted Therapies Market Analysis
-
8.1 Europe Neoantigen Targeted Therapies Market, by Type
-
8.2 Europe Neoantigen Targeted Therapies Market, by Application
-
8.3 Europe Neoantigen Targeted Therapies Market Analysis and Forecast, by Country
-
8.3.1 Germany Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Neoantigen Targeted Therapies Market Analysis
-
9.1 APAC Neoantigen Targeted Therapies Market, by Type
-
9.2 APAC Neoantigen Targeted Therapies Market, by Application
-
9.3 APAC Neoantigen Targeted Therapies Market Analysis and Forecast, by Country
-
9.3.1 China Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Neoantigen Targeted Therapies Market Analysis
-
10.1 Latin America, Middle East and Africa Neoantigen Targeted Therapies Market, by Type
-
10.2 Latin America, Middle East and Africa Neoantigen Targeted Therapies Market, by Application
-
10.3 Latin America, Middle East and Africa Neoantigen Targeted Therapies Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Neoantigen Targeted Therapies Company Profiles
-
11.1 Precision Biologics
-
11.1.1 Precision Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Precision Biologics Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.1.3 Precision Biologics Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Gradalis
-
11.2.1 Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Gradalis Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.2.3 Gradalis Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Genocea Biosciences
-
11.3.1 Genocea Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Genocea Biosciences Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.3.3 Genocea Biosciences Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Neon Therapeutics
-
11.4.1 Neon Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Neon Therapeutics Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.4.3 Neon Therapeutics Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Iovance Biotherapeutics
-
11.5.1 Iovance Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Iovance Biotherapeutics Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.5.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Vaxon Biotech
-
11.6.1 Vaxon Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Vaxon Biotech Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.6.3 Vaxon Biotech Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Bavarian Nordic
-
11.7.1 Bavarian Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Bavarian Nordic Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.7.3 Bavarian Nordic Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Immunovative Therapies
-
11.8.1 Immunovative Therapies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Immunovative Therapies Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.8.3 Immunovative Therapies Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Immunicum
-
11.9.1 Immunicum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Immunicum Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.9.3 Immunicum Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Medigene
-
11.10.1 Medigene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Medigene Neoantigen Targeted Therapies Product Profiles, Application and Specification
-
11.10.3 Medigene Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Neoantigen Targeted Therapies Industry Investment Prospect and Risk Assessment
-
12.1 Neoantigen Targeted Therapies Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Neoantigen Targeted Therapies Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure China Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Production Value and Growth Rate (2017-2028)
-
Figure China Neoantigen Targeted Therapies Production Value and Growth Rate (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Market Size and Growth Rate of Monotherapy (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Market Size and Growth Rate of Combination Therapy (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Market Size and Growth Rate of Medical Research Institution (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Market Size and Growth Rate of Hospital and Clinic (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Neoantigen Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Neoantigen Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Neoantigen Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Neoantigen Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Neoantigen Targeted Therapies Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Neoantigen Targeted Therapies Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Neoantigen Targeted Therapies Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Neoantigen Targeted Therapies Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Neoantigen Targeted Therapies Market Share, by Manufacturer in 2021
-
Figure Global and China Neoantigen Targeted Therapies Market Share, by Manufacturer in 2022
-
Table Global Neoantigen Targeted Therapies Sales Volume, by Type (2017-2028)
-
Table Global Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Table Global Neoantigen Targeted Therapies Sales Value, by Type (2017-2028)
-
Table Global Neoantigen Targeted Therapies Sales Value Share, by Type (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Price Trend, by Type (2017-2028)
-
Table China Neoantigen Targeted Therapies Sales Volume, by Type (2017-2028)
-
Table China Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Figure China Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Table China Neoantigen Targeted Therapies Sales Value, by Type (2017-2028)
-
Table China Neoantigen Targeted Therapies Sales Value Share, by Type (2017-2028)
-
Figure China Neoantigen Targeted Therapies Price Trend, by Type (2017-2028)
-
Table Global Neoantigen Targeted Therapies Sales Volume, by Application (2017-2028)
-
Table Global Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Table Global Neoantigen Targeted Therapies Sales Value, by Application (2017-2028)
-
Table Global Neoantigen Targeted Therapies Sales Value Share, by Application (2017-2028)
-
Figure Global Neoantigen Targeted Therapies Sales Value Share, by Application (2017-2028)
-
Table China Neoantigen Targeted Therapies Sales Volume, by Application (2017-2028)
-
Table China Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure China Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Table China Neoantigen Targeted Therapies Sales Value, by Application (2017-2028)
-
Table China Neoantigen Targeted Therapies Sales Value Share, by Application (2017-2028)
-
Figure China Neoantigen Targeted Therapies Sales Value Share, by Application (2017-2028)
-
Figure China Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
-
Figure North America Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Neoantigen Targeted Therapies Production, Import, Consumption and Export (2017-2022)
-
Table North America Neoantigen Targeted Therapies Sales Volume, by Type (2017-2028)
-
Table North America Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Figure North America Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Table North America Neoantigen Targeted Therapies Sales Volume, by Application (2017-2028)
-
Table North America Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure North America Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure United States Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure United States Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Canada Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Table Europe Neoantigen Targeted Therapies Sales Volume, by Type (2017-2028)
-
Table Europe Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Figure Europe Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Table Europe Neoantigen Targeted Therapies Sales Volume, by Application (2017-2028)
-
Table Europe Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure Europe Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure Germany Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure UK Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure UK Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure France Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure France Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Italy Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Spain Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Poland Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Russia Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Table APAC Neoantigen Targeted Therapies Sales Volume, by Type (2017-2028)
-
Table APAC Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Figure APAC Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Table APAC Neoantigen Targeted Therapies Sales Volume, by Application (2017-2028)
-
Table APAC Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure APAC Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure China Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure China Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Japan Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure India Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure India Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Neoantigen Targeted Therapies Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Neoantigen Targeted Therapies Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neoantigen Targeted Therapies Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Neoantigen Targeted Therapies Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Neoantigen Targeted Therapies Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Neoantigen Targeted Therapies Sales Value and Growth Rate (2017-2028)
-
Table Precision Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Precision Biologics Product Profiles, Application and Specification
-
Table Precision Biologics Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gradalis Product Profiles, Application and Specification
-
Table Gradalis Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genocea Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genocea Biosciences Product Profiles, Application and Specification
-
Table Genocea Biosciences Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Neon Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Neon Therapeutics Product Profiles, Application and Specification
-
Table Neon Therapeutics Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Iovance Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Iovance Biotherapeutics Product Profiles, Application and Specification
-
Table Iovance Biotherapeutics Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Vaxon Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Vaxon Biotech Product Profiles, Application and Specification
-
Table Vaxon Biotech Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bavarian Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bavarian Nordic Product Profiles, Application and Specification
-
Table Bavarian Nordic Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Immunovative Therapies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Immunovative Therapies Product Profiles, Application and Specification
-
Table Immunovative Therapies Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Immunicum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Immunicum Product Profiles, Application and Specification
-
Table Immunicum Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Medigene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Medigene Product Profiles, Application and Specification
-
Table Medigene Neoantigen Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
